Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2017 Mar 7

PMID 28260841

Citations 18

Authors

D Dreymueller

K Theodorou

M Donners

A Ludwig

Affiliations

Soon will be listed here.

Abstract

Cell migration is an instrumental process involved in organ development, tissue homeostasis, and various physiological processes and also in numerous pathologies. Both basic cell migration and migration towards chemotactic stimulus consist of changes in cell polarity and cytoskeletal rearrangement, cell detachment from, invasion through, and reattachment to their neighboring cells, and numerous interactions with the extracellular matrix. The different steps of immune cell, tissue cell, or cancer cell migration are tightly coordinated in time and place by growth factors, cytokines/chemokines, adhesion molecules, and receptors for these ligands. This review describes how a disintegrin and metalloproteinases interfere with several steps of cell migration, either by proteolytic cleavage of such molecules or by functions independent of proteolytic activity.

Citing Articles

Regulation of ADAM10 activity through microdomain-dependent intracellular calcium changes.

Gharzia F, Aljohmani A, Beck A, Philipp S, Yildiz D Cell Commun Signal. 2024; 22(1):531.

PMID: 39497138 PMC: 11533308. DOI: 10.1186/s12964-024-01891-5.

Phenotype Compensation in Reproductive ADAM Gene Family: A Case Study with ADAM27 Knockout Mouse.

Khezri J, Hasheni E, Shams Ara M, Rahim Tayefe A, Heidari F Iran J Biotechnol. 2024; 20(4):e2902.

PMID: 38344314 PMC: 10858364. DOI: 10.30498/ijb.2022.250175.2902.

Endothelial ADAM10 controls cellular response to oxLDL and its deficiency exacerbates atherosclerosis with intraplaque hemorrhage and neovascularization in mice.

van der Vorst E, Maas S, Theodorou K, Peters L, Jin H, Rademakers T Front Cardiovasc Med. 2023; 10:974918.

PMID: 36776254 PMC: 9911417. DOI: 10.3389/fcvm.2023.974918.

ADAM17-mediated EGFR ligand shedding directs macrophage-promoted cancer cell invasion.

Gnosa S, Blasco L, Piotrowski K, Freiberg M, Savickas S, Madsen D JCI Insight. 2022; 7(18).

PMID: 35998057 PMC: 9675555. DOI: 10.1172/jci.insight.155296.

Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression.

Kudling T, Clubb J, Quixabeira D, Santos J, Havunen R, Kononov A Oncoimmunology. 2022; 11(1):2096572.

PMID: 35845722 PMC: 9278414. DOI: 10.1080/2162402X.2022.2096572.

References

Janes P, Saha N, Barton W, Kolev M, Wimmer-Kleikamp S, Nievergall E . Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell. 2005; 123(2):291-304. DOI: 10.1016/j.cell.2005.08.014. View

van Haastert P, Devreotes P . Chemotaxis: signalling the way forward. Nat Rev Mol Cell Biol. 2004; 5(8):626-34. DOI: 10.1038/nrm1435. View

Mishra H, Long C, Bahaie N, Walcheck B . Regulation of CXCR2 expression and function by a disintegrin and metalloprotease-17 (ADAM17). J Leukoc Biol. 2014; 97(3):447-54. PMC: 4338845. DOI: 10.1189/jlb.3HI0714-340R. View

Romagnoli M, Mineva N, Polmear M, Conrad C, Srinivasan S, Loussouarn D . ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis. EMBO Mol Med. 2013; 6(2):278-94. PMC: 3927960. DOI: 10.1002/emmm.201303373. View

Amour A, Slocombe P, Webster A, Butler M, Knight C, Smith B . TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 1998; 435(1):39-44. DOI: 10.1016/s0014-5793(98)01031-x. View

Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Gast D, Joumaa S . ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J. 2002; 17(2):292-4. DOI: 10.1096/fj.02-0430fje. View

Scholz F, Schulte A, Adamski F, Hundhausen C, Mittag J, Schwarz A . Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin. J Invest Dermatol. 2007; 127(6):1444-55. DOI: 10.1038/sj.jid.5700751. View

Kania A, Klein R . Mechanisms of ephrin-Eph signalling in development, physiology and disease. Nat Rev Mol Cell Biol. 2016; 17(4):240-56. DOI: 10.1038/nrm.2015.16. View

Kieseier B, Pischel H, Neuen-Jacob E, Tourtellotte W, Hartung H . ADAM-10 and ADAM-17 in the inflamed human CNS. Glia. 2003; 42(4):398-405. DOI: 10.1002/glia.10226. View

10.

Bakken A, Protack C, Roztocil E, Nicholl S, Davies M . Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism. J Vasc Surg. 2009; 49(5):1296-303. PMC: 2691776. DOI: 10.1016/j.jvs.2008.12.026. View

11.

Wehr A, Baeck C, Ulmer F, Gassler N, Hittatiya K, Luedde T . Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. PLoS One. 2014; 9(11):e112327. PMC: 4221470. DOI: 10.1371/journal.pone.0112327. View

12.

Jalili A, Shirvaikar N, Marquez-Curtis L, Turner A, Janowska-Wieczorek A . The HGF/c-Met axis synergizes with G-CSF in the mobilization of hematopoietic stem/progenitor cells. Stem Cells Dev. 2009; 19(8):1143-51. DOI: 10.1089/scd.2009.0376. View

13.

Harsha A, Stojadinovic O, Brem H, Sehara-Fujisawa A, Wewer U, Loomis C . ADAM12: a potential target for the treatment of chronic wounds. J Mol Med (Berl). 2008; 86(8):961-9. PMC: 2674959. DOI: 10.1007/s00109-008-0353-z. View

14.

Mauch C, Zamek J, Abety A, Grimberg G, Fox J, Zigrino P . Accelerated wound repair in ADAM-9 knockout animals. J Invest Dermatol. 2010; 130(8):2120-30. DOI: 10.1038/jid.2010.60. View

15.

Peschon J, Slack J, Reddy P, Stocking K, Sunnarborg S, Lee D . An essential role for ectodomain shedding in mammalian development. Science. 1998; 282(5392):1281-4. DOI: 10.1126/science.282.5392.1281. View

16.

Jones A, Lambert D, Speight P, Whawell S . ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with αvβ6 integrin. FEBS Lett. 2013; 587(21):3529-34. DOI: 10.1016/j.febslet.2013.09.010. View

17.

Hundhausen C, Misztela D, Berkhout T, Broadway N, Saftig P, Reiss K . The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood. 2003; 102(4):1186-95. DOI: 10.1182/blood-2002-12-3775. View

18.

Gregory A, Dendrou C, Attfield K, Haghikia A, Xifara D, Butter F . TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature. 2012; 488(7412):508-511. PMC: 4268493. DOI: 10.1038/nature11307. View

19.

Holloway J, Laxton R, Rose-Zerilli M, Holloway J, Andrews A, Riaz Z . ADAM33 expression in atherosclerotic lesions and relationship of ADAM33 gene variation with atherosclerosis. Atherosclerosis. 2010; 211(1):224-30. DOI: 10.1016/j.atherosclerosis.2010.02.023. View

20.

Hundhausen C, Schulte A, Schulz B, Andrzejewski M, Schwarz N, von Hundelshausen P . Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol. 2007; 178(12):8064-72. DOI: 10.4049/jimmunol.178.12.8064. View